Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

Primary care physicians and urologists work together to provide optimal care for men with low-risk prostate cancer

Primary care physicians and urologists work together to provide optimal care for men with low-risk prostate cancer

FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma

FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma

ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer

ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer

ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low-risk, stage IIA colon cancer

ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low...

CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies

CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies

AI harnesses tumour genetics to predict treatment response

AI harnesses tumour genetics to predict treatment response

Ageing in cells may boost ovarian cancer spread

Ageing in cells may boost ovarian cancer spread

Aberrant RBMX expression relevant for cancer prognosis and immunotherapy response

Aberrant RBMX expression relevant for cancer prognosis and immunotherapy response

ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

Bladder tumours reduced by 90% using nanorobots

Bladder tumours reduced by 90% using nanorobots

More from ecancer